Government Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
Pfizer's COVID-19 Oral Antiviral Treatment Transitioning from Government Distribution
As COVID-19 continues to impact our communities, and winter approaches—bringing with it increases in respiratory infections—it’s important to stay vigilant and up to date on vaccines and to understand how to access treatment when appropriate. Pfizer’s oral antiviral COVID-19 treatment has been an important tool against the virus since its authorization in December 2021. Thanks to an agreement with the U.S. government, it will soon be easier for eligible patients to access Pfizer’s COVID-19...
Reasons To Reject Massachusetts’ Misguided Drug Pricing Bill
Massachusetts state legislators are considering a dangerous bill that could stifle innovation, limit patients’ access to medicines, and interfere with market competition. The bill would grant the state government broad authority to arbitrarily set the prices of medications, which could threaten the biopharmaceutical industry’s contributions to the state’s economy.We all share the goal of ensuring that life-saving medicines are accessible and affordable for all, but this misguided bill is not the...
Insurers and middlemen profiting more from prescription drugs
Vaccines continue to help keep millions safe despite an ever-changing adversary, and there is new hope in the form of treatments that may prevent the most severe outcomes when infections do occur. While science drives us forward, we are also focused on the common goal of finding ways to lower healthcare costs for patients.As we all look for policies to achieve that goal, it’s imperative to look at all the cost drivers in the prescription drug system, and new data demonstrates for the first time...
Reasons to Reject the Dangerous Medicare Pricing Proposal
Making sure that medicines are accessible and affordable for patients is a goal we all share. But policymakers are considering a dangerous Medicare reform policy that could threaten the future of groundbreaking cures.The policy would allow government “negotiations” on the price of medicines for Medicare, and would give government a greater hand in dictating prices, rather than the current system that promotes competition. Moreover, this misguided policy would repeal a key provision of the...
Reasons to Reject H.R. 3
Making sure that medicines are accessible and affordable for patients is a goal we all share. But the dangerous policy outlined in H.R. 3 could threaten the future of groundbreaking cures.The policy would allow government “negotiations” on the price of medicines for Medicare. Moreover, this misguided policy would repeal a key provision of the Medicare Part D program – the noninterference clause – that protects coverage and access to medicines for seniors and people with disabilities. Taking away...
Why Foreign Drug Pricing Policies Don’t Work
Congress is considering passing a drug pricing policy that could threaten the future of groundbreaking cures! The policy would adopt similar policies that foreign countries use to restrict access to medicine.There are major problems with this policy:It puts innovation at risk. The policy could lead to an estimated 60 fewer new treatments over the next three decades. A new study by the Congressional Budget Office found that it would result in fewer groundbreaking treatments for patients in...
Government Price-Setting Is Not the Answer
Making sure that medicines are accessible and affordable for patients is a goal we all share. But Congress is considering a dangerous proposal that could jeopardize the development of lifesaving medicines, vaccines, and treatments. The proposal calls for implementation of a government price-setting model that could undermine Medicare protections that provide patients robust choice and access to the medicines they need.The proposal would allow the government to dictate the price of medicines for...
Wisconsin is Ready for Cures
Pfizer is focused on increasing treatment options for patients through research and development as well as innovative, technically advanced manufacturing practices. We’re proud to be strengthening our capacity to develop and produce more advanced medicines that can help improve the lives of patients. As part of that effort, we recently announced an $18 million expansion of Pfizer’s distribution center in Pleasant Prairie, Wisconsin.Pfizer’s Pleasant Prairie facility is key to distributing Pfizer...
Michigan is Ready for Cures
Pfizer is focused on increasing treatment options for patients through research and development as well as innovative, technically advanced manufacturing practices. We’re proud to be strengthening our capacity to develop and produce more advanced medicines that can help improve the lives of patients. As part of that effort, we recently announced a $450 million expansion of Pfizer’s largest manufacturing facility in Kalamazoo, Michigan.Pfizer’s Kalamazoo Portage campus is a primary global...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.